To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
4 Current news from israelrss
Epigenomics expands commercial reach for CE-marked product beyond home market
Epigenomics AG and Pronto Diagnostics Ltd. announced that they have signed an exclusive distributor agreement for the commercialization of Epigenomics’ Epi proColon test in Israel. Epi proColon is the world’s first CE-marked molecular diagnostic test for the early detection of colorectal cancer ...
Chronic pain is a serious medical problem, afflicting approximately 20% of adults. Some individuals are more susceptible than others, and the basis for this remains largely unknown. In a report published in Genome Research, researchers have identified a gene associated with susceptibility to ...
Pluristem Therapeutics Inc. announced interim top-line results from its Phase I clinical trials utilizing its placenta-derived cell therapy product, PLX-PAD, for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD). The interim data demonstrated that ...
BioLineRx, a drug development company with products in advanced clinical and pre-clinical testing, announced the initiation of a Phase I/II clinical trial aimed at assessing the safety and efficacy of BL-5010, a novel formulation for the non surgical removal of skin lesions. The open-label, ...